http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e1ddd14ae09830c6608fdcf0307e363a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Burgess |
| name | Teresa L. Burgess |
| given-name | Teresa L. |
| organization-name | 5Department of Cancer Biology, Amgen, Inc., Thousand Oaks, California 1Oncology Research, Departments of Departments of Oncology Research, Protein Sciences, and Clinical Immunology, Amgen, Inc., Thousand Oaks, California Authors' Affiliation: Department of Oncology Research, Amgen, Inc., Thousand Oaks, California *Department of Mammalian Cell Molecular Biology, ‡Department of Pathology, §Department of Protein Chemistry, and ‖Department of Cell Biology, Amgen Inc., Thousand Oaks, California 91320-1789 Amgen Inc., Thousand Oaks, California. Authors' Affiliations: 1Premiere Oncology of Arizona, Scottsdale, Arizona; 2Indiana University School of Medicine, Indianapolis, Indiana; 3University of Colorado Cancer Center, Aurora, Colorado; and 4Amgen Inc., Thousand Oaks, California Authors' Affiliations: 1Oncology Research, 2Protein Science, 3Clinical Immunology, and 4High Throughput Screening-Molecular Pharmacology, Amgen Inc., Thousand Oaks, California; 5Department of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, California; and 6Laboratory of Cancer Biology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland 1Laboratory of Molecular Oncology, 2Laboratory of Antibody Technology, and 3Laboratory of Computational Biology, Van Andel Research Institute, Grand Rapids, Michigan; and 4Amgen, Inc., Thousand Oaks, California, Department Oncology Research Departments of Medicinal Chemistry, Molecular Structure, Oncology Research, Pharmaceutics, and Pharmacokinetics and Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 Authors' Affiliations: Departments of 1Hematology & Oncology Research, 2Pharmacokinetics & Drug Metabolism, 3Pathology and Comparative Biology Safety Sciences, 4Medicinal Chemistry, and 5Pharmaceutics, Amgen, Inc., Thousand Oaks, California; and 6Department of Molecular Structure, Amgen Inc., Cambridge, Massachusetts Authors' Affiliations: 1Department of Pediatric Oncology, and 2Center for Sarcoma and Bone Oncology, Ludwig Center for Cancer Research, Dana-Farber Cancer Institute; 3Division of Hematology/Oncology, Department of Medicine, Children's Hospital Boston; 4Harvard Medical School, Boston, Massachusetts; 5Departments of Pediatrics and Genetics, Lineberger Comprehensive Cancer Center, North Carolina Children's Hospital, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; and 6Department of Oncology Research, Amgen, Inc., Thousand Oaks, California |
Incoming Links
Total number of triples: 41.